Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Working Capital Changes: 2011-2025

Historic Other Working Capital Changes for Capricor Therapeutics (CAPR) over the last 13 years, with Sep 2025 value amounting to $966,329.

  • Capricor Therapeutics' Other Working Capital Changes rose 142.73% to $966,329 in Q3 2025 from the same period last year, while for Sep 2025 it was -$362,423, marking a year-over-year increase of 97.26%. This contributed to the annual value of -$12.3 million for FY2024, which is 286.10% down from last year.
  • Latest data reveals that Capricor Therapeutics reported Other Working Capital Changes of $966,329 as of Q3 2025, which was up 969.81% from -$111,096 recorded in Q2 2025.
  • Capricor Therapeutics' 5-year Other Working Capital Changes high stood at $30.0 million for Q1 2022, and its period low was -$6.2 million during Q3 2023.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$2.1 million (2023), whereas its average is -$1.3 million.
  • In the last 5 years, Capricor Therapeutics' Other Working Capital Changes slumped by 415.30% in 2021 and then spiked by 113,107.55% in 2022.
  • Capricor Therapeutics' Other Working Capital Changes (Quarterly) stood at $881,028 in 2021, then plummeted by 208.95% to -$959,903 in 2022, then slumped by 117.53% to -$2.1 million in 2023, then soared by 45.86% to -$1.1 million in 2024, then skyrocketed by 142.73% to $966,329 in 2025.
  • Its Other Working Capital Changes was $966,329 in Q3 2025, compared to -$111,096 in Q2 2025 and -$87,147 in Q1 2025.